Global Meningococcal Vaccine Market By Brand (Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands), By Type (Bivalent, Quadrivalent and Other Types), By Age Group (Infants (0 to 2 years) and Children (2 years & above)), By Region, Industry Analysis and Forecast, 2020 - 2026
Published Date : 5-Feb-2021 | Pages: 201 | Formats: PDF |
COVID-19 Impact on the Meningococcal Vaccine Market
Market Overview
The Global Meningococcal Vaccine Market size is expected to reach $4.5 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Meningococcal meningitis is a bacterial infection that is caused by gram-negative bacteria, Neisseria meningitides that includes a spectrum of infections such as bacteremia (meningococcemia), meningitis, and bacteremia pneumonia.
The meningococcal disease is very rare but is highly fatal, if left untreated, up to 50% of the patients die or get some serious complications thereafter. In meningococcal meningitis, bacteria infect the lining of the brain and spinal cord and can potentially cause large endemics as well as epidemics. The disease is transmitted from an infected person through direct contact with droplets of the throat or respiratory secretions, asymptomatic carriers can also capable of transmitting infection.
There is an increasing prevalence of various types of bacteria that cause meningococcal meningitis. The most common type of meningitis causing bacteria are A, B, C, W, Y, and type X that was more lately reported in Africa, continue to underline the criticality of more effective vaccine of meningococcal to be available in the coming years.
Over the past few decades, cases of meningitis have been increased and are one of the key factors likely to drive the market for meningococcal vaccines. According to the Centers for Disease Control and Prevention (CDC), about 1.2 million cases of meningococcal meningitis are estimated to occur worldwide every year. The government and regulatory authorities are taking initiatives to combat the increasing prevalence of meningitis are likely to drive the market growth. For example, “Defeating meningitis by 2030” was introduced in 2018 at the World Health Assembly by Eastern Mediterranean and African regions. This program is focused to develop a strategic roadmap for the prevention of meningitis by prioritizing research and improved control activities.
By Brand
Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. The MenACWY vaccine and MenC vaccine are expected to experience swift growth during the forecast period. This is accredited to the increased adoption of these vaccines in several countries across the globe through immunization programs. Furthermore, outbreaks of meningococcal in several countries resulted in an increasing demand for meningococcal vaccines, which further boost the growth of the meningococcal vaccine market.
By Type
Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Quadrivalent meningococcal vaccines had the largest revenue share of the market in 2019, owing to the increased used brands like Menveo, Menactra, and Nimenrix, for this category. New vaccines are increasingly approved that will protect people against meningococcal meningitis and is expected to boost the growth of this market.
By Age Group
Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). The infant segment is anticipated to be the fastest-growing segment in the coming years due to the increasing incidence of meningitis among infants. According to the European Centre for Disease Prevention and Control (ECDC), IMD incidence was observed highest in infants in 2017. In Europe, there were nearly 8.2 confirmed cases per 100,000 populations in children below one year.
| Report Attribute | Details |
|---|---|
| Market size value in 2019 | USD 2.6 Billion |
| Market size forecast in 2026 | USD 4.5 Billion |
| Base Year | 2019 |
| Historical Period | 2016 to 2018 |
| Forecast Period | 2020 to 2026 |
| Revenue Growth Rate | CAGR of 8.5% from 2020 to 2026 |
| Number of Pages | 201 |
| Number of Tables | 370 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling, Competition Analysis |
| Segments covered | Brand, Type, Age Group, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
By Region
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America led the market and had a significant revenue share of the market in 2019 which is followed by Europe. Favorable approvals, supportive initiatives by the government, and high investments in R&D are the major factors fueling the North American market.
Free Valuable Insights: Global Meningococcal Vaccine Market to reach a market size of $4.5 Billion by 2026
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.).
Recent Strategies Deployed in Meningococcal Vaccine Market
- Dec-2020: Serum Institute of India (SII) launched world's most affordable pneumococcal conjugate vaccine (PCV) in India. This vaccine provides protection against 10 variants of pneumococcus bacteria that causes pneumonia, meningitis, ear, and blood infections in children.
- Dec-2020: The Oswaldo Cruz Foundation, through the Institute of Technology in Immunobiologicals (Bio-Manguinhos) announced an agreement with the Government of the State of Rio de Janerio. Following this agreement, the Industrial Complex of Biotechnology in Health (Cibs) will be built, in the Industrial District of Santa Cruz, in Rio de Janeiro. The new plant aims to enable the production of new vaccines, such as the bivalent vaccine (measles and rubella), clinical studies of which were recently concluded by Bio-Manguinhos, and meningococcal C, which is in an advanced stage of studies phases II/III, in addition to new vaccine presentations from the Institute's portfolio (number of doses/bottle), to meet different needs of the health system.
- Nov-2020: Sanofi's MenQuadfi received approval from The European Commission (EC) for active immunization of individuals from the age of 12 months and older against invasive meningococcal disease. This disease is caused by Neisseria meningitidis serogroups A, C, W and Y. The MenQuadfi has been delivering optimized stability while maintaining the vaccine in a convenient, fully liquid presentation. Apr-2018: Pfizer's TRUMENBA (Meningococcal Group B Vaccine) received approval from the U.S. Food and Drug Administration (FDA). This vaccine is being used for active immunization for preventing invasive disease caused by Neisseria meningitidis group B (MenB) in children ages 1 through 9 years.
- Apr-2020: MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine received Biologics License Application approval from FDA. This vaccine has been used for the prevention of invasive meningococcal disease in persons 2 years of age and older.
- Feb-2018: GlaxoSmithKline announced that it received Breakthrough Therapy Designation from FDA for its meningitis B vaccine Bexsero for developing vaccine in the prevention of Invasive Meningococcal Disease (IMD) caused by serogroup B in children 2-10 years of age.
- May-2017: Pfizer announced that European Commission approved TRUMENBA (Meningococcal Group B Vaccine). This vaccine aimed to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years of age and older.
- Dec-2016: Pfizer got approval from European Commission for Nimenrix (meningococcal group A, C, W-135, and Y conjugate vaccine). This vaccine was developed for active immunization against invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135, and Y (MenACWY) in infants as early as six weeks of age.
Scope of the Study
Market Segments Covered in the Report:
By Brand
- Bexsero
- Trumenba
- Nimenrix
- Menactra
- Menveo
- Other Brands
By Type
- Bivalent
- Quadrivalent
- Other Types
By Age Group
- Infants (0 to 2 years)
- Children (2 years & above)
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Sanofi S.A.
- Walvax Biotechnology Co., Ltd.
- Bio-Manguinhos (Oswaldo Cruz Foundation)
- Bio-Med Pvt. Ltd.
- Chongqing Zhifei Biological Products Co., Ltd.
- Hualan Biological Engineering, Inc.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Meningococcal Vaccine Market, by Brand
1.4.2 Global Meningococcal Vaccine Market, by Type
1.4.3 Global Meningococcal Vaccine Market, by Age Group
1.4.4 Global Meningococcal Vaccine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Global Meningococcal Vaccine Market by Brand
4.1 Global Bexsero Market by Region
4.2 Global Trumenba Market by Region
4.3 Global Nimenrix Market by Region
4.4 Global Menactra Market by Region
4.5 Global Menveo Market by Region
4.6 Global Other Brands Market by Region
Chapter 5. Global Meningococcal Vaccine Market by Type
5.1 Global Bivalent Market by Region
5.2 Global Quadrivalent Market by Region
5.3 Global Other Types Market by Region
Chapter 6. Global Meningococcal Vaccine Market by Age Group
6.1 Global Children (2 years & above) and Adults Market by Region
6.2 Global Infants(0 to 2 years) Market by Region
Chapter 7. Global Meningococcal Vaccine Market by Region
7.1 North America Meningococcal Vaccine Market
7.1.1 North America Meningococcal Vaccine Market by Brand
7.1.1.1 North America Bexsero Market by Country
7.1.1.2 North America Trumenba Market by Country
7.1.1.3 North America Nimenrix Market by Country
7.1.1.4 North America Menactra Market by Country
7.1.1.5 North America Menveo Market by Country
7.1.1.6 North America Other Brands Market by Country
7.1.2 North America Meningococcal Vaccine Market by Type
7.1.2.1 North America Bivalent Market by Country
7.1.2.2 North America Quadrivalent Market by Country
7.1.2.3 North America Other Types Market by Country
7.1.3 North America Meningococcal Vaccine Market by Age Group
7.1.3.1 North America Children (2 years & above) and Adults Market by Country
7.1.3.2 North America Infants(0 to 2 years) Market by Country
7.1.4 North America Meningococcal Vaccine Market by Country
7.1.4.1 USA Meningococcal Vaccine Market
7.1.4.1.1 USA Meningococcal Vaccine Market by Brand
7.1.4.1.2 USA Meningococcal Vaccine Market by Type
7.1.4.1.3 USA Meningococcal Vaccine Market by Age Group
7.1.4.2 Canada Meningococcal Vaccine Market
7.1.4.2.1 Canada Meningococcal Vaccine Market by Brand
7.1.4.2.2 Canada Meningococcal Vaccine Market by Type
7.1.4.2.3 Canada Meningococcal Vaccine Market by Age Group
7.1.4.3 Mexico Meningococcal Vaccine Market
7.1.4.3.1 Mexico Meningococcal Vaccine Market by Brand
7.1.4.3.2 Mexico Meningococcal Vaccine Market by Type
7.1.4.3.3 Mexico Meningococcal Vaccine Market by Age Group
7.1.4.4 Rest of North America Meningococcal Vaccine Market
7.1.4.4.1 Rest of North America Meningococcal Vaccine Market by Brand
7.1.4.4.2 Rest of North America Meningococcal Vaccine Market by Type
7.1.4.4.3 Rest of North America Meningococcal Vaccine Market by Age Group
7.2 Europe Meningococcal Vaccine Market
7.2.1 Europe Meningococcal Vaccine Market by Brand
7.2.1.1 Europe Bexsero Market by Country
7.2.1.2 Europe Trumenba Market by Country
7.2.1.3 Europe Nimenrix Market by Country
7.2.1.4 Europe Menactra Market by Country
7.2.1.5 Europe Menveo Market by Country
7.2.1.6 Europe Other Brands Market by Country
7.2.2 Europe Meningococcal Vaccine Market by Type
7.2.2.1 Europe Bivalent Market by Country
7.2.2.2 Europe Quadrivalent Market by Country
7.2.2.3 Europe Other Types Market by Country
7.2.3 Europe Meningococcal Vaccine Market by Age Group
7.2.3.1 Europe Children (2 years & above) and Adults Market by Country
7.2.3.2 Europe Infants(0 to 2 years) Market by Country
7.2.4 Europe Meningococcal Vaccine Market by Country
7.2.4.1 Germany Meningococcal Vaccine Market
7.2.4.1.1 Germany Meningococcal Vaccine Market by Brand
7.2.4.1.2 Germany Meningococcal Vaccine Market by Type
7.2.4.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2.4.2 UK Meningococcal Vaccine Market
7.2.4.2.1 UK Meningococcal Vaccine Market by Brand
7.2.4.2.2 UK Meningococcal Vaccine Market by Type
7.2.4.2.3 UK Meningococcal Vaccine Market by Age Group
7.2.4.3 France Meningococcal Vaccine Market
7.2.4.3.1 France Meningococcal Vaccine Market by Brand
7.2.4.3.2 France Meningococcal Vaccine Market by Type
7.2.4.3.3 France Meningococcal Vaccine Market by Age Group
7.2.4.4 Russia Meningococcal Vaccine Market
7.2.4.4.1 Russia Meningococcal Vaccine Market by Brand
7.2.4.4.2 Russia Meningococcal Vaccine Market by Type
7.2.4.4.3 Russia Meningococcal Vaccine Market by Age Group
7.2.4.5 Spain Meningococcal Vaccine Market
7.2.4.5.1 Spain Meningococcal Vaccine Market by Brand
7.2.4.5.2 Spain Meningococcal Vaccine Market by Type
7.2.4.5.3 Spain Meningococcal Vaccine Market by Age Group
7.2.4.6 Italy Meningococcal Vaccine Market
7.2.4.6.1 Italy Meningococcal Vaccine Market by Brand
7.2.4.6.2 Italy Meningococcal Vaccine Market by Type
7.2.4.6.3 Italy Meningococcal Vaccine Market by Age Group
7.2.4.7 Rest of Europe Meningococcal Vaccine Market
7.2.4.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.2.4.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.2.4.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group
7.3 Asia Pacific Meningococcal Vaccine Market
7.3.1 Asia Pacific Meningococcal Vaccine Market by Brand
7.3.1.1 Asia Pacific Bexsero Market by Country
7.3.1.2 Asia Pacific Trumenba Market by Country
7.3.1.3 Asia Pacific Nimenrix Market by Country
7.3.1.4 Asia Pacific Menactra Market by Country
7.3.1.5 Asia Pacific Menveo Market by Country
7.3.1.6 Asia Pacific Other Brands Market by Country
7.3.2 Asia Pacific Meningococcal Vaccine Market by Type
7.3.2.1 Asia Pacific Bivalent Market by Country
7.3.2.2 Asia Pacific Quadrivalent Market by Country
7.3.2.3 Asia Pacific Other Types Market by Country
7.3.3 Asia Pacific Meningococcal Vaccine Market by Age Group
7.3.3.1 Asia Pacific Children (2 years & above) and Adults Market by Country
7.3.3.2 Asia Pacific Infants(0 to 2 years) Market by Country
7.3.4 Asia Pacific Meningococcal Vaccine Market by Country
7.3.4.1 China Meningococcal Vaccine Market
7.3.4.1.1 China Meningococcal Vaccine Market by Brand
7.3.4.1.2 China Meningococcal Vaccine Market by Type
7.3.4.1.3 China Meningococcal Vaccine Market by Age Group
7.3.4.2 India Meningococcal Vaccine Market
7.3.4.2.1 India Meningococcal Vaccine Market by Brand
7.3.4.2.2 India Meningococcal Vaccine Market by Type
7.3.4.2.3 India Meningococcal Vaccine Market by Age Group
7.3.4.3 Japan Meningococcal Vaccine Market
7.3.4.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.4.3.2 Japan Meningococcal Vaccine Market by Type
7.3.4.3.3 Japan Meningococcal Vaccine Market by Age Group
7.3.4.4 South Korea Meningococcal Vaccine Market
7.3.4.4.1 South Korea Meningococcal Vaccine Market by Brand
7.3.4.4.2 South Korea Meningococcal Vaccine Market by Type
7.3.4.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.3.4.5 Singapore Meningococcal Vaccine Market
7.3.4.5.1 Singapore Meningococcal Vaccine Market by Brand
7.3.4.5.2 Singapore Meningococcal Vaccine Market by Type
7.3.4.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.3.4.6 Malaysia Meningococcal Vaccine Market
7.3.4.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.3.4.6.2 Malaysia Meningococcal Vaccine Market by Type
7.3.4.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.3.4.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.3.4.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.3.4.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.3.4.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group
7.4 LAMEA Meningococcal Vaccine Market
7.4.1 LAMEA Meningococcal Vaccine Market by Brand
7.4.1.1 LAMEA Bexsero Market by Country
7.4.1.2 LAMEA Trumenba Market by Country
7.4.1.3 LAMEA Nimenrix Market by Country
7.4.1.4 LAMEA Menactra Market by Country
7.4.1.5 LAMEA Menveo Market by Country
7.4.1.6 LAMEA Other Brands Market by Country
7.4.2 LAMEA Meningococcal Vaccine Market by Type
7.4.2.1 LAMEA Bivalent Market by Country
7.4.2.2 LAMEA Quadrivalent Market by Country
7.4.2.3 LAMEA Other Types Market by Country
7.4.3 LAMEA Meningococcal Vaccine Market by Age Group
7.4.3.1 LAMEA Children (2 years & above) and Adults Market by Country
7.4.3.2 LAMEA Infants(0 to 2 years) Market by Country
7.4.4 LAMEA Meningococcal Vaccine Market by Country
7.4.4.1 Brazil Meningococcal Vaccine Market
7.4.4.1.1 Brazil Meningococcal Vaccine Market by Brand
7.4.4.1.2 Brazil Meningococcal Vaccine Market by Type
7.4.4.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.4.4.2 Argentina Meningococcal Vaccine Market
7.4.4.2.1 Argentina Meningococcal Vaccine Market by Brand
7.4.4.2.2 Argentina Meningococcal Vaccine Market by Type
7.4.4.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.4.4.3 UAE Meningococcal Vaccine Market
7.4.4.3.1 UAE Meningococcal Vaccine Market by Brand
7.4.4.3.2 UAE Meningococcal Vaccine Market by Type
7.4.4.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4.4.4 Saudi Arabia Meningococcal Vaccine Market
7.4.4.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.4.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.4.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.4.4.5 South Africa Meningococcal Vaccine Market
7.4.4.5.1 South Africa Meningococcal Vaccine Market by Brand
7.4.4.5.2 South Africa Meningococcal Vaccine Market by Type
7.4.4.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.4.4.6 Nigeria Meningococcal Vaccine Market
7.4.4.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.4.4.6.2 Nigeria Meningococcal Vaccine Market by Type
7.4.4.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.4.4.7 Rest of LAMEA Meningococcal Vaccine Market
7.4.4.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.4.4.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.4.4.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Meningococcal Vaccine Market, by Brand
1.4.2 Global Meningococcal Vaccine Market, by Type
1.4.3 Global Meningococcal Vaccine Market, by Age Group
1.4.4 Global Meningococcal Vaccine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Global Meningococcal Vaccine Market by Brand
4.1 Global Bexsero Market by Region
4.2 Global Trumenba Market by Region
4.3 Global Nimenrix Market by Region
4.4 Global Menactra Market by Region
4.5 Global Menveo Market by Region
4.6 Global Other Brands Market by Region
Chapter 5. Global Meningococcal Vaccine Market by Type
5.1 Global Bivalent Market by Region
5.2 Global Quadrivalent Market by Region
5.3 Global Other Types Market by Region
Chapter 6. Global Meningococcal Vaccine Market by Age Group
6.1 Global Children (2 years & above) and Adults Market by Region
6.2 Global Infants(0 to 2 years) Market by Region
Chapter 7. Global Meningococcal Vaccine Market by Region
7.1 North America Meningococcal Vaccine Market
7.1.1 North America Meningococcal Vaccine Market by Brand
7.1.1.1 North America Bexsero Market by Country
7.1.1.2 North America Trumenba Market by Country
7.1.1.3 North America Nimenrix Market by Country
7.1.1.4 North America Menactra Market by Country
7.1.1.5 North America Menveo Market by Country
7.1.1.6 North America Other Brands Market by Country
7.1.2 North America Meningococcal Vaccine Market by Type
7.1.2.1 North America Bivalent Market by Country
7.1.2.2 North America Quadrivalent Market by Country
7.1.2.3 North America Other Types Market by Country
7.1.3 North America Meningococcal Vaccine Market by Age Group
7.1.3.1 North America Children (2 years & above) and Adults Market by Country
7.1.3.2 North America Infants(0 to 2 years) Market by Country
7.1.4 North America Meningococcal Vaccine Market by Country
7.1.4.1 USA Meningococcal Vaccine Market
7.1.4.1.1 USA Meningococcal Vaccine Market by Brand
7.1.4.1.2 USA Meningococcal Vaccine Market by Type
7.1.4.1.3 USA Meningococcal Vaccine Market by Age Group
7.1.4.2 Canada Meningococcal Vaccine Market
7.1.4.2.1 Canada Meningococcal Vaccine Market by Brand
7.1.4.2.2 Canada Meningococcal Vaccine Market by Type
7.1.4.2.3 Canada Meningococcal Vaccine Market by Age Group
7.1.4.3 Mexico Meningococcal Vaccine Market
7.1.4.3.1 Mexico Meningococcal Vaccine Market by Brand
7.1.4.3.2 Mexico Meningococcal Vaccine Market by Type
7.1.4.3.3 Mexico Meningococcal Vaccine Market by Age Group
7.1.4.4 Rest of North America Meningococcal Vaccine Market
7.1.4.4.1 Rest of North America Meningococcal Vaccine Market by Brand
7.1.4.4.2 Rest of North America Meningococcal Vaccine Market by Type
7.1.4.4.3 Rest of North America Meningococcal Vaccine Market by Age Group
7.2 Europe Meningococcal Vaccine Market
7.2.1 Europe Meningococcal Vaccine Market by Brand
7.2.1.1 Europe Bexsero Market by Country
7.2.1.2 Europe Trumenba Market by Country
7.2.1.3 Europe Nimenrix Market by Country
7.2.1.4 Europe Menactra Market by Country
7.2.1.5 Europe Menveo Market by Country
7.2.1.6 Europe Other Brands Market by Country
7.2.2 Europe Meningococcal Vaccine Market by Type
7.2.2.1 Europe Bivalent Market by Country
7.2.2.2 Europe Quadrivalent Market by Country
7.2.2.3 Europe Other Types Market by Country
7.2.3 Europe Meningococcal Vaccine Market by Age Group
7.2.3.1 Europe Children (2 years & above) and Adults Market by Country
7.2.3.2 Europe Infants(0 to 2 years) Market by Country
7.2.4 Europe Meningococcal Vaccine Market by Country
7.2.4.1 Germany Meningococcal Vaccine Market
7.2.4.1.1 Germany Meningococcal Vaccine Market by Brand
7.2.4.1.2 Germany Meningococcal Vaccine Market by Type
7.2.4.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2.4.2 UK Meningococcal Vaccine Market
7.2.4.2.1 UK Meningococcal Vaccine Market by Brand
7.2.4.2.2 UK Meningococcal Vaccine Market by Type
7.2.4.2.3 UK Meningococcal Vaccine Market by Age Group
7.2.4.3 France Meningococcal Vaccine Market
7.2.4.3.1 France Meningococcal Vaccine Market by Brand
7.2.4.3.2 France Meningococcal Vaccine Market by Type
7.2.4.3.3 France Meningococcal Vaccine Market by Age Group
7.2.4.4 Russia Meningococcal Vaccine Market
7.2.4.4.1 Russia Meningococcal Vaccine Market by Brand
7.2.4.4.2 Russia Meningococcal Vaccine Market by Type
7.2.4.4.3 Russia Meningococcal Vaccine Market by Age Group
7.2.4.5 Spain Meningococcal Vaccine Market
7.2.4.5.1 Spain Meningococcal Vaccine Market by Brand
7.2.4.5.2 Spain Meningococcal Vaccine Market by Type
7.2.4.5.3 Spain Meningococcal Vaccine Market by Age Group
7.2.4.6 Italy Meningococcal Vaccine Market
7.2.4.6.1 Italy Meningococcal Vaccine Market by Brand
7.2.4.6.2 Italy Meningococcal Vaccine Market by Type
7.2.4.6.3 Italy Meningococcal Vaccine Market by Age Group
7.2.4.7 Rest of Europe Meningococcal Vaccine Market
7.2.4.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.2.4.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.2.4.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group
7.3 Asia Pacific Meningococcal Vaccine Market
7.3.1 Asia Pacific Meningococcal Vaccine Market by Brand
7.3.1.1 Asia Pacific Bexsero Market by Country
7.3.1.2 Asia Pacific Trumenba Market by Country
7.3.1.3 Asia Pacific Nimenrix Market by Country
7.3.1.4 Asia Pacific Menactra Market by Country
7.3.1.5 Asia Pacific Menveo Market by Country
7.3.1.6 Asia Pacific Other Brands Market by Country
7.3.2 Asia Pacific Meningococcal Vaccine Market by Type
7.3.2.1 Asia Pacific Bivalent Market by Country
7.3.2.2 Asia Pacific Quadrivalent Market by Country
7.3.2.3 Asia Pacific Other Types Market by Country
7.3.3 Asia Pacific Meningococcal Vaccine Market by Age Group
7.3.3.1 Asia Pacific Children (2 years & above) and Adults Market by Country
7.3.3.2 Asia Pacific Infants(0 to 2 years) Market by Country
7.3.4 Asia Pacific Meningococcal Vaccine Market by Country
7.3.4.1 China Meningococcal Vaccine Market
7.3.4.1.1 China Meningococcal Vaccine Market by Brand
7.3.4.1.2 China Meningococcal Vaccine Market by Type
7.3.4.1.3 China Meningococcal Vaccine Market by Age Group
7.3.4.2 India Meningococcal Vaccine Market
7.3.4.2.1 India Meningococcal Vaccine Market by Brand
7.3.4.2.2 India Meningococcal Vaccine Market by Type
7.3.4.2.3 India Meningococcal Vaccine Market by Age Group
7.3.4.3 Japan Meningococcal Vaccine Market
7.3.4.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.4.3.2 Japan Meningococcal Vaccine Market by Type
7.3.4.3.3 Japan Meningococcal Vaccine Market by Age Group
7.3.4.4 South Korea Meningococcal Vaccine Market
7.3.4.4.1 South Korea Meningococcal Vaccine Market by Brand
7.3.4.4.2 South Korea Meningococcal Vaccine Market by Type
7.3.4.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.3.4.5 Singapore Meningococcal Vaccine Market
7.3.4.5.1 Singapore Meningococcal Vaccine Market by Brand
7.3.4.5.2 Singapore Meningococcal Vaccine Market by Type
7.3.4.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.3.4.6 Malaysia Meningococcal Vaccine Market
7.3.4.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.3.4.6.2 Malaysia Meningococcal Vaccine Market by Type
7.3.4.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.3.4.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.3.4.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.3.4.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.3.4.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group
7.4 LAMEA Meningococcal Vaccine Market
7.4.1 LAMEA Meningococcal Vaccine Market by Brand
7.4.1.1 LAMEA Bexsero Market by Country
7.4.1.2 LAMEA Trumenba Market by Country
7.4.1.3 LAMEA Nimenrix Market by Country
7.4.1.4 LAMEA Menactra Market by Country
7.4.1.5 LAMEA Menveo Market by Country
7.4.1.6 LAMEA Other Brands Market by Country
7.4.2 LAMEA Meningococcal Vaccine Market by Type
7.4.2.1 LAMEA Bivalent Market by Country
7.4.2.2 LAMEA Quadrivalent Market by Country
7.4.2.3 LAMEA Other Types Market by Country
7.4.3 LAMEA Meningococcal Vaccine Market by Age Group
7.4.3.1 LAMEA Children (2 years & above) and Adults Market by Country
7.4.3.2 LAMEA Infants(0 to 2 years) Market by Country
7.4.4 LAMEA Meningococcal Vaccine Market by Country
7.4.4.1 Brazil Meningococcal Vaccine Market
7.4.4.1.1 Brazil Meningococcal Vaccine Market by Brand
7.4.4.1.2 Brazil Meningococcal Vaccine Market by Type
7.4.4.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.4.4.2 Argentina Meningococcal Vaccine Market
7.4.4.2.1 Argentina Meningococcal Vaccine Market by Brand
7.4.4.2.2 Argentina Meningococcal Vaccine Market by Type
7.4.4.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.4.4.3 UAE Meningococcal Vaccine Market
7.4.4.3.1 UAE Meningococcal Vaccine Market by Brand
7.4.4.3.2 UAE Meningococcal Vaccine Market by Type
7.4.4.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4.4.4 Saudi Arabia Meningococcal Vaccine Market
7.4.4.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.4.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.4.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.4.4.5 South Africa Meningococcal Vaccine Market
7.4.4.5.1 South Africa Meningococcal Vaccine Market by Brand
7.4.4.5.2 South Africa Meningococcal Vaccine Market by Type
7.4.4.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.4.4.6 Nigeria Meningococcal Vaccine Market
7.4.4.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.4.4.6.2 Nigeria Meningococcal Vaccine Market by Type
7.4.4.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.4.4.7 Rest of LAMEA Meningococcal Vaccine Market
7.4.4.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.4.4.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.4.4.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
List of Tables
TABLE 1 Global Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 2 Global Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 Global Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 Global Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 Global Bexsero Market by Region, 2016 - 2019, USD Million
TABLE 6 Global Bexsero Market by Region, 2020 - 2026, USD Million
TABLE 7 Global Trumenba Market by Region, 2016 - 2019, USD Million
TABLE 8 Global Trumenba Market by Region, 2020 - 2026, USD Million
TABLE 9 Global Nimenrix Market by Region, 2016 - 2019, USD Million
TABLE 10 Global Nimenrix Market by Region, 2020 - 2026, USD Million
TABLE 11 Global Menactra Market by Region, 2016 - 2019, USD Million
TABLE 12 Global Menactra Market by Region, 2020 - 2026, USD Million
TABLE 13 Global Menveo Market by Region, 2016 - 2019, USD Million
TABLE 14 Global Menveo Market by Region, 2020 - 2026, USD Million
TABLE 15 Global Other Brands Market by Region, 2016 - 2019, USD Million
TABLE 16 Global Other Brands Market by Region, 2020 - 2026, USD Million
TABLE 17 Global Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 Global Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 Global Bivalent Market by Region, 2016 - 2019, USD Million
TABLE 20 Global Bivalent Market by Region, 2020 - 2026, USD Million
TABLE 21 Global Quadrivalent Market by Region, 2016 - 2019, USD Million
TABLE 22 Global Quadrivalent Market by Region, 2020 - 2026, USD Million
TABLE 23 Global Other Types Market by Region, 2016 - 2019, USD Million
TABLE 24 Global Other Types Market by Region, 2020 - 2026, USD Million
TABLE 25 Global Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 Global Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 Global Children (2 years & above) and Adults Market by Region, 2016 - 2019, USD Million
TABLE 28 Global Children (2 years & above) and Adults Market by Region, 2020 - 2026, USD Million
TABLE 29 Global Infants(0 to 2 years) Market by Region, 2016 - 2019, USD Million
TABLE 30 Global Infants(0 to 2 years) Market by Region, 2020 - 2026, USD Million
TABLE 31 Global Meningococcal Vaccine Market by Region, 2016 - 2019, USD Million
TABLE 32 Global Meningococcal Vaccine Market by Region, 2020 - 2026, USD Million
TABLE 33 North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 North America Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 38 North America Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 39 North America Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 40 North America Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 41 North America Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 42 North America Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 43 North America Menactra Market by Country, 2016 - 2019, USD Million
TABLE 44 North America Menactra Market by Country, 2020 - 2026, USD Million
TABLE 45 North America Menveo Market by Country, 2016 - 2019, USD Million
TABLE 46 North America Menveo Market by Country, 2020 - 2026, USD Million
TABLE 47 North America Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 48 North America Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 49 North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 50 North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 51 North America Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 52 North America Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 53 North America Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 54 North America Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 55 North America Other Types Market by Country, 2016 - 2019, USD Million
TABLE 56 North America Other Types Market by Country, 2020 - 2026, USD Million
TABLE 57 North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 58 North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 59 North America Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 60 North America Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 61 North America Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 62 North America Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 63 North America Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 64 North America Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 65 USA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 66 USA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 67 USA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 68 USA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 69 USA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 70 USA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 71 USA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 72 USA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 73 Canada Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 74 Canada Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 75 Canada Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 76 Canada Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 77 Canada Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 78 Canada Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 79 Canada Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 80 Canada Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 81 Mexico Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 82 Mexico Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 83 Mexico Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 84 Mexico Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 85 Mexico Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 86 Mexico Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 87 Mexico Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 88 Mexico Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 89 Rest of North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 90 Rest of North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 91 Rest of North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 92 Rest of North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 93 Rest of North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 94 Rest of North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 95 Rest of North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 96 Rest of North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 97 Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 98 Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 99 Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 100 Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 101 Europe Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 102 Europe Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 103 Europe Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 104 Europe Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 105 Europe Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 106 Europe Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 107 Europe Menactra Market by Country, 2016 - 2019, USD Million
TABLE 108 Europe Menactra Market by Country, 2020 - 2026, USD Million
TABLE 109 Europe Menveo Market by Country, 2016 - 2019, USD Million
TABLE 110 Europe Menveo Market by Country, 2020 - 2026, USD Million
TABLE 111 Europe Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 112 Europe Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 113 Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 114 Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 115 Europe Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 116 Europe Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 117 Europe Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 118 Europe Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 119 Europe Other Types Market by Country, 2016 - 2019, USD Million
TABLE 120 Europe Other Types Market by Country, 2020 - 2026, USD Million
TABLE 121 Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 122 Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 123 Europe Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 124 Europe Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 125 Europe Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 126 Europe Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 127 Europe Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 128 Europe Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 129 Germany Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 130 Germany Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 131 Germany Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 132 Germany Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 133 Germany Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 134 Germany Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 135 Germany Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 136 Germany Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 137 UK Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 138 UK Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 139 UK Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 140 UK Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 141 UK Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 142 UK Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 143 UK Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 144 UK Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 145 France Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 146 France Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 147 France Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 148 France Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 149 France Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 150 France Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 151 France Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 152 France Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 153 Russia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 154 Russia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 155 Russia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 156 Russia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 157 Russia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 158 Russia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 159 Russia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 160 Russia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 161 Spain Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 162 Spain Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 163 Spain Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 164 Spain Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 165 Spain Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 166 Spain Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 167 Spain Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 168 Spain Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 169 Italy Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 170 Italy Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 171 Italy Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 172 Italy Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 173 Italy Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 174 Italy Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 175 Italy Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 176 Italy Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 177 Rest of Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 178 Rest of Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 179 Rest of Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 180 Rest of Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 181 Rest of Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 182 Rest of Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 183 Rest of Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 184 Rest of Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 185 Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 186 Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 187 Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 188 Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 189 Asia Pacific Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 190 Asia Pacific Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 191 Asia Pacific Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 192 Asia Pacific Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 193 Asia Pacific Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 194 Asia Pacific Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 195 Asia Pacific Menactra Market by Country, 2016 - 2019, USD Million
TABLE 196 Asia Pacific Menactra Market by Country, 2020 - 2026, USD Million
TABLE 197 Asia Pacific Menveo Market by Country, 2016 - 2019, USD Million
TABLE 198 Asia Pacific Menveo Market by Country, 2020 - 2026, USD Million
TABLE 199 Asia Pacific Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 200 Asia Pacific Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 201 Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 202 Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 203 Asia Pacific Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 204 Asia Pacific Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 205 Asia Pacific Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 206 Asia Pacific Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 207 Asia Pacific Other Types Market by Country, 2016 - 2019, USD Million
TABLE 208 Asia Pacific Other Types Market by Country, 2020 - 2026, USD Million
TABLE 209 Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 210 Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 211 Asia Pacific Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 212 Asia Pacific Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 213 Asia Pacific Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 214 Asia Pacific Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 215 Asia Pacific Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 216 Asia Pacific Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 217 China Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 218 China Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 219 China Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 220 China Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 221 China Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 222 China Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 223 China Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 224 China Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 225 India Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 226 India Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 227 India Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 228 India Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 229 India Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 230 India Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 231 India Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 232 India Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 233 Japan Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 234 Japan Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 235 Japan Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 236 Japan Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 237 Japan Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 238 Japan Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 239 Japan Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 240 Japan Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 241 South Korea Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 242 South Korea Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 243 South Korea Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 244 South Korea Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 245 South Korea Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 246 South Korea Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 247 South Korea Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 248 South Korea Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 249 Singapore Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 250 Singapore Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 251 Singapore Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 252 Singapore Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 253 Singapore Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 254 Singapore Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 255 Singapore Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 256 Singapore Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 257 Malaysia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 258 Malaysia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 259 Malaysia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 260 Malaysia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 261 Malaysia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 262 Malaysia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 263 Malaysia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 264 Malaysia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 265 Rest of Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 266 Rest of Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 267 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 268 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 269 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 270 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 271 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 272 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 273 LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 274 LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 275 LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 276 LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 277 LAMEA Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 278 LAMEA Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 279 LAMEA Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 280 LAMEA Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 281 LAMEA Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 282 LAMEA Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 283 LAMEA Menactra Market by Country, 2016 - 2019, USD Million
TABLE 284 LAMEA Menactra Market by Country, 2020 - 2026, USD Million
TABLE 285 LAMEA Menveo Market by Country, 2016 - 2019, USD Million
TABLE 286 LAMEA Menveo Market by Country, 2020 - 2026, USD Million
TABLE 287 LAMEA Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 288 LAMEA Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 289 LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 290 LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 291 LAMEA Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 292 LAMEA Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 293 LAMEA Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 294 LAMEA Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 295 LAMEA Other Types Market by Country, 2016 - 2019, USD Million
TABLE 296 LAMEA Other Types Market by Country, 2020 - 2026, USD Million
TABLE 297 LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 298 LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 299 LAMEA Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 300 LAMEA Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 301 LAMEA Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 302 LAMEA Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 303 LAMEA Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 304 LAMEA Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 305 Brazil Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 306 Brazil Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 307 Brazil Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 308 Brazil Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 309 Brazil Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 310 Brazil Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 311 Brazil Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 312 Brazil Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 313 Argentina Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 314 Argentina Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 315 Argentina Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 316 Argentina Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 317 Argentina Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 318 Argentina Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 319 Argentina Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 320 Argentina Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 321 UAE Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 322 UAE Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 323 UAE Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 324 UAE Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 325 UAE Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 326 UAE Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 327 UAE Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 328 UAE Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 329 Saudi Arabia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 330 Saudi Arabia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 331 Saudi Arabia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 332 Saudi Arabia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 333 Saudi Arabia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 334 Saudi Arabia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 335 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 336 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 337 South Africa Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 338 South Africa Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 339 South Africa Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 340 South Africa Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 341 South Africa Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 342 South Africa Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 343 South Africa Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 344 South Africa Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 345 Nigeria Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 346 Nigeria Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 347 Nigeria Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 348 Nigeria Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 349 Nigeria Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 350 Nigeria Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 351 Nigeria Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 352 Nigeria Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 353 Rest of LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 354 Rest of LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 355 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 356 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 357 Rest of LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 358 Rest of LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 359 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 360 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 361 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 362 Key Information – Pfizer, Inc.
TABLE 363 Key Information – Sanofi S.A.
TABLE 364 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 365 Key Information – Bio-Manguinhos
TABLE 366 key information – Bio-Med Pvt. Ltd.
TABLE 367 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 368 Key Information – Hualan Biological Engineering, Inc.
TABLE 369 key information – Incepta Pharmaceuticals Ltd.
TABLE 370 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
TABLE 2 Global Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 Global Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 Global Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 Global Bexsero Market by Region, 2016 - 2019, USD Million
TABLE 6 Global Bexsero Market by Region, 2020 - 2026, USD Million
TABLE 7 Global Trumenba Market by Region, 2016 - 2019, USD Million
TABLE 8 Global Trumenba Market by Region, 2020 - 2026, USD Million
TABLE 9 Global Nimenrix Market by Region, 2016 - 2019, USD Million
TABLE 10 Global Nimenrix Market by Region, 2020 - 2026, USD Million
TABLE 11 Global Menactra Market by Region, 2016 - 2019, USD Million
TABLE 12 Global Menactra Market by Region, 2020 - 2026, USD Million
TABLE 13 Global Menveo Market by Region, 2016 - 2019, USD Million
TABLE 14 Global Menveo Market by Region, 2020 - 2026, USD Million
TABLE 15 Global Other Brands Market by Region, 2016 - 2019, USD Million
TABLE 16 Global Other Brands Market by Region, 2020 - 2026, USD Million
TABLE 17 Global Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 Global Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 Global Bivalent Market by Region, 2016 - 2019, USD Million
TABLE 20 Global Bivalent Market by Region, 2020 - 2026, USD Million
TABLE 21 Global Quadrivalent Market by Region, 2016 - 2019, USD Million
TABLE 22 Global Quadrivalent Market by Region, 2020 - 2026, USD Million
TABLE 23 Global Other Types Market by Region, 2016 - 2019, USD Million
TABLE 24 Global Other Types Market by Region, 2020 - 2026, USD Million
TABLE 25 Global Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 Global Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 Global Children (2 years & above) and Adults Market by Region, 2016 - 2019, USD Million
TABLE 28 Global Children (2 years & above) and Adults Market by Region, 2020 - 2026, USD Million
TABLE 29 Global Infants(0 to 2 years) Market by Region, 2016 - 2019, USD Million
TABLE 30 Global Infants(0 to 2 years) Market by Region, 2020 - 2026, USD Million
TABLE 31 Global Meningococcal Vaccine Market by Region, 2016 - 2019, USD Million
TABLE 32 Global Meningococcal Vaccine Market by Region, 2020 - 2026, USD Million
TABLE 33 North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 North America Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 38 North America Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 39 North America Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 40 North America Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 41 North America Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 42 North America Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 43 North America Menactra Market by Country, 2016 - 2019, USD Million
TABLE 44 North America Menactra Market by Country, 2020 - 2026, USD Million
TABLE 45 North America Menveo Market by Country, 2016 - 2019, USD Million
TABLE 46 North America Menveo Market by Country, 2020 - 2026, USD Million
TABLE 47 North America Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 48 North America Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 49 North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 50 North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 51 North America Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 52 North America Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 53 North America Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 54 North America Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 55 North America Other Types Market by Country, 2016 - 2019, USD Million
TABLE 56 North America Other Types Market by Country, 2020 - 2026, USD Million
TABLE 57 North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 58 North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 59 North America Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 60 North America Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 61 North America Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 62 North America Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 63 North America Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 64 North America Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 65 USA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 66 USA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 67 USA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 68 USA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 69 USA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 70 USA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 71 USA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 72 USA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 73 Canada Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 74 Canada Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 75 Canada Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 76 Canada Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 77 Canada Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 78 Canada Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 79 Canada Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 80 Canada Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 81 Mexico Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 82 Mexico Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 83 Mexico Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 84 Mexico Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 85 Mexico Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 86 Mexico Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 87 Mexico Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 88 Mexico Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 89 Rest of North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 90 Rest of North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 91 Rest of North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 92 Rest of North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 93 Rest of North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 94 Rest of North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 95 Rest of North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 96 Rest of North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 97 Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 98 Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 99 Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 100 Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 101 Europe Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 102 Europe Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 103 Europe Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 104 Europe Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 105 Europe Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 106 Europe Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 107 Europe Menactra Market by Country, 2016 - 2019, USD Million
TABLE 108 Europe Menactra Market by Country, 2020 - 2026, USD Million
TABLE 109 Europe Menveo Market by Country, 2016 - 2019, USD Million
TABLE 110 Europe Menveo Market by Country, 2020 - 2026, USD Million
TABLE 111 Europe Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 112 Europe Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 113 Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 114 Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 115 Europe Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 116 Europe Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 117 Europe Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 118 Europe Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 119 Europe Other Types Market by Country, 2016 - 2019, USD Million
TABLE 120 Europe Other Types Market by Country, 2020 - 2026, USD Million
TABLE 121 Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 122 Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 123 Europe Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 124 Europe Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 125 Europe Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 126 Europe Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 127 Europe Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 128 Europe Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 129 Germany Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 130 Germany Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 131 Germany Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 132 Germany Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 133 Germany Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 134 Germany Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 135 Germany Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 136 Germany Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 137 UK Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 138 UK Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 139 UK Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 140 UK Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 141 UK Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 142 UK Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 143 UK Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 144 UK Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 145 France Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 146 France Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 147 France Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 148 France Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 149 France Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 150 France Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 151 France Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 152 France Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 153 Russia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 154 Russia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 155 Russia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 156 Russia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 157 Russia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 158 Russia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 159 Russia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 160 Russia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 161 Spain Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 162 Spain Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 163 Spain Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 164 Spain Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 165 Spain Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 166 Spain Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 167 Spain Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 168 Spain Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 169 Italy Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 170 Italy Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 171 Italy Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 172 Italy Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 173 Italy Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 174 Italy Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 175 Italy Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 176 Italy Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 177 Rest of Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 178 Rest of Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 179 Rest of Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 180 Rest of Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 181 Rest of Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 182 Rest of Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 183 Rest of Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 184 Rest of Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 185 Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 186 Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 187 Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 188 Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 189 Asia Pacific Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 190 Asia Pacific Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 191 Asia Pacific Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 192 Asia Pacific Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 193 Asia Pacific Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 194 Asia Pacific Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 195 Asia Pacific Menactra Market by Country, 2016 - 2019, USD Million
TABLE 196 Asia Pacific Menactra Market by Country, 2020 - 2026, USD Million
TABLE 197 Asia Pacific Menveo Market by Country, 2016 - 2019, USD Million
TABLE 198 Asia Pacific Menveo Market by Country, 2020 - 2026, USD Million
TABLE 199 Asia Pacific Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 200 Asia Pacific Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 201 Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 202 Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 203 Asia Pacific Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 204 Asia Pacific Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 205 Asia Pacific Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 206 Asia Pacific Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 207 Asia Pacific Other Types Market by Country, 2016 - 2019, USD Million
TABLE 208 Asia Pacific Other Types Market by Country, 2020 - 2026, USD Million
TABLE 209 Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 210 Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 211 Asia Pacific Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 212 Asia Pacific Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 213 Asia Pacific Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 214 Asia Pacific Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 215 Asia Pacific Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 216 Asia Pacific Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 217 China Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 218 China Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 219 China Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 220 China Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 221 China Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 222 China Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 223 China Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 224 China Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 225 India Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 226 India Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 227 India Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 228 India Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 229 India Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 230 India Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 231 India Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 232 India Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 233 Japan Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 234 Japan Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 235 Japan Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 236 Japan Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 237 Japan Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 238 Japan Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 239 Japan Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 240 Japan Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 241 South Korea Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 242 South Korea Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 243 South Korea Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 244 South Korea Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 245 South Korea Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 246 South Korea Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 247 South Korea Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 248 South Korea Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 249 Singapore Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 250 Singapore Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 251 Singapore Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 252 Singapore Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 253 Singapore Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 254 Singapore Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 255 Singapore Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 256 Singapore Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 257 Malaysia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 258 Malaysia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 259 Malaysia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 260 Malaysia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 261 Malaysia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 262 Malaysia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 263 Malaysia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 264 Malaysia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 265 Rest of Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 266 Rest of Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 267 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 268 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 269 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 270 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 271 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 272 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 273 LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 274 LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 275 LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 276 LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 277 LAMEA Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 278 LAMEA Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 279 LAMEA Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 280 LAMEA Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 281 LAMEA Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 282 LAMEA Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 283 LAMEA Menactra Market by Country, 2016 - 2019, USD Million
TABLE 284 LAMEA Menactra Market by Country, 2020 - 2026, USD Million
TABLE 285 LAMEA Menveo Market by Country, 2016 - 2019, USD Million
TABLE 286 LAMEA Menveo Market by Country, 2020 - 2026, USD Million
TABLE 287 LAMEA Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 288 LAMEA Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 289 LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 290 LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 291 LAMEA Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 292 LAMEA Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 293 LAMEA Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 294 LAMEA Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 295 LAMEA Other Types Market by Country, 2016 - 2019, USD Million
TABLE 296 LAMEA Other Types Market by Country, 2020 - 2026, USD Million
TABLE 297 LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 298 LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 299 LAMEA Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 300 LAMEA Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 301 LAMEA Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 302 LAMEA Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 303 LAMEA Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 304 LAMEA Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 305 Brazil Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 306 Brazil Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 307 Brazil Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 308 Brazil Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 309 Brazil Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 310 Brazil Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 311 Brazil Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 312 Brazil Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 313 Argentina Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 314 Argentina Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 315 Argentina Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 316 Argentina Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 317 Argentina Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 318 Argentina Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 319 Argentina Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 320 Argentina Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 321 UAE Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 322 UAE Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 323 UAE Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 324 UAE Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 325 UAE Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 326 UAE Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 327 UAE Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 328 UAE Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 329 Saudi Arabia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 330 Saudi Arabia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 331 Saudi Arabia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 332 Saudi Arabia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 333 Saudi Arabia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 334 Saudi Arabia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 335 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 336 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 337 South Africa Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 338 South Africa Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 339 South Africa Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 340 South Africa Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 341 South Africa Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 342 South Africa Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 343 South Africa Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 344 South Africa Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 345 Nigeria Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 346 Nigeria Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 347 Nigeria Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 348 Nigeria Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 349 Nigeria Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 350 Nigeria Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 351 Nigeria Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 352 Nigeria Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 353 Rest of LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 354 Rest of LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 355 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 356 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 357 Rest of LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 358 Rest of LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 359 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 360 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 361 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 362 Key Information – Pfizer, Inc.
TABLE 363 Key Information – Sanofi S.A.
TABLE 364 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 365 Key Information – Bio-Manguinhos
TABLE 366 key information – Bio-Med Pvt. Ltd.
TABLE 367 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 368 Key Information – Hualan Biological Engineering, Inc.
TABLE 369 key information – Incepta Pharmaceuticals Ltd.
TABLE 370 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research